from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2331/-

LFCtreatmentdescriptionclass of inhibitor

1.224

Amikacinug/mL Amikacintranslation

1.063

Cap5-10ug/mL Capreomycintranslation

1.846

Rox10-50 ug/mL Roxithromycintranslation

-0.246

SM2-5 ug/mL Streptomycintranslation

2.387

Tet5-10 ug/mL Tetracyclinetranslation

0.978

Rif0.2-5ug/mL Rifampicintranscription

-0.379

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.184

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.971

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.278

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.795

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.396

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.171

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.850

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.398

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.863

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.684

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.559

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.415

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.870

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.079

KCN5-20 ug/mL Potassium cyaniderespiration

-0.120

NaN30.2-2 mM Sodium aziderespiration

-0.484

Nigericin50 uM Nigericinrespiration

-1.069

TRC10-150 ug/mL Triclosanrespiration

-0.228

TRZ10-25 ug/mL Thioridazinerespiration

1.124

Valinomycin0.5-10 uM Valinomycinrespiration

0.868

ZnSO42 mM ZnSO4respiration

-0.383

menadione6-10 ug/mL Menadionerespiration

-0.728

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.304

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.969

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.346

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.011

NRP_1Non-replicating persistence stage 1dosRassociated

0.402

Amp0.2mg/mL AmpicillincellWall

0.168

Cephalexin20-100 ug/mL CephalexincellWall

-0.138

Cerulenin0.32-5 ug/mL CerulenincellWall

0.449

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.563

EMB10-20 ug/mL EthambutolcellWall

0.198

Eta12-40 ug/mL EthionamidecellWall

0.657

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.311

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.057

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.002

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.492

BZA0.12 mg/mL BenzamidearomaticAmides

-0.047

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.189

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.464

H2O24 mM hydrogen peroxideDNAdamaging

-0.361

Levo10 ug/mL LevofloxacinDNAdamaging

-0.296

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.542

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.232

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.031

UVUV-irradiationDNAdamaging

-0.770

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.949

Antimycin12.5-50 ug/mL Antimycin A?

0.154

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.954

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.898

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.752

PA8240.2-2 ug/mL PA-824?

1.023

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.029

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.136

Verapamil50 uM Verapamil?

-0.394

mercaptoethanol2 mM 2-Mercaptoethanol?

0.163

methoxatin10-20 ug/mL Methoxatin?